Osaic Holdings
TOVX icon

Osaic Holdings’s Theriva Biologics TOVX Stock Holding History

Osaic Holdings’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110 Buy
441
+433
+5,413% +$128 ﹤0.01% 7832
2026
Q1 		$1 Sell
8
-440
-98% -$87 ﹤0.01% 7798
2025
Q4 		$93 Buy
448
+4
+0.9% +$1 ﹤0.01% 7657
2025
Q3 		$172 Hold
444
– – ﹤0.01% 7709
2025
Q2 		$190 Sell
444
-440
-50% -$357 ﹤0.01% 7510
2025
Q1 		$972 Sell
884
-410
-32% -$573 ﹤0.01% 6829
2024
Q4 		$2.26K Hold
1,294
– – ﹤0.01% 6561
2024
Q3 		$1.78K Buy
1,294
+852
+193% +$4.16K ﹤0.01% 6660
2024
Q2 		$2.61K Buy
442
+440
+22,000% +$3.85K ﹤0.01% 6498
2024
Q1 		$21 Hold
2
– – ﹤0.01% 7121
2023
Q4 		$20 Sell
2
-2
-50% -$25 ﹤0.01% 7206
2023
Q3 		$47 Buy
4
+2
+100% +$30 ﹤0.01% 7277
2023
Q2 		$47 Hold
2
– – ﹤0.01% 7332
2023
Q1 		$32 Hold
2
– – ﹤0.01% 7403
2022
Q4 		$0 Hold
2
– – ﹤0.01% 7428
2022
Q3 		$0 Hold
2
– – ﹤0.01% 7507
2022
Q2 		$0 Hold
2
– – ﹤0.01% 7596
2022
Q1 		$0 Hold
2
– – ﹤0.01% 7502
2021
Q4 		$0 Hold
2
– – ﹤0.01% 7571
2021
Q3 		$0 Hold
2
– – ﹤0.01% 7308
2021
Q2 		$0 Hold
2
– – ﹤0.01% 7127
2021
Q1 		$0 Hold
2
– – ﹤0.01% 6947
2020
Q4 		$0 Hold
2
– – ﹤0.01% 6562
2020
Q3 		$0 Hold
2
– – ﹤0.01% 6401
2020
Q2 		$0 Hold
2
– – ﹤0.01% 6327
2020
Q1 		$0 Buy
+2
New +$228 ﹤0.01% 6183

Other funds holding TOVX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Osaic Holdings's TOVX Position: Q2 2026 in Review

Osaic Holdings increased its Theriva Biologics (TOVX) stake by 5,413% in Q2 2026, buying an estimated $128 and bringing the position to 441 shares worth $110. The position accounts for ﹤0.01% of the portfolio, ranked #7832.

Osaic Holdings first reported a position in TOVX in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.61K in Q2 2024. 26 funds tracked by Wall St. Rank hold TOVX as of Q2 2026.

  • Osaic Holdings held 441 shares of Theriva Biologics worth $110 as of Q2 2026.
  • Osaic Holdings bought 433 Theriva Biologics shares in Q2 2026, an estimated $128.
  • Theriva Biologics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7832 holding.
  • Osaic Holdings first reported a position in Theriva Biologics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Theriva Biologics position peaked at $2.61K in Q2 2024.
  • 26 funds tracked by Wall St. Rank held Theriva Biologics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.